Skip to search formSkip to main contentSkip to account menu

lysomustine

Known as: lysomustin 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Nitrosourea Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Cytotoxicity of lysomustine and its isomers, and their potential use for selection of cells
Nɛ-Nitroso-Nɛ-[N′-(2-chloroethyl)carbamoyl]-L-lysine (I) and Nɛ-[N′-(2-chloroethyl)-N′-nitrosocarbamoyl]-L-lysine (II), the… 
2010
2010
Selection of genetically modified hematopoietic cells in vitro and in vivo using alkylating agent lysomustine.
2005
2005
Сравнительное изучение противоопухолевой активности липосомальных лекарственных форм препаратов производных нитрозоалкилмочевины
Lysomustine is an original antitumor preparation, chloroethylic derivative of nitrosourea on L-homocitrulline basis. BCNU is 1,3… 
2004
2004
Determining Technological Impurities in Lysomustin
The optimum ratio of isomers (1)/(2) in lysomustin is 3 : 1 [1]. The industrial drug quality standard [2] restricts the content… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)